247 related articles for article (PubMed ID: 34026604)
41. Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm.
Lei X; Zhou N; Zhang H; Li T; Ren F; Zhang B; Li X; Zu L; Song Z; Xu S
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805037
[TBL] [Abstract][Full Text] [Related]
42. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
[TBL] [Abstract][Full Text] [Related]
43. Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study.
Ling L; Zheng H; Lin H; Ge C; Li D; Wu L; Lou Y; Jiang T; Fu J
Clin Lung Cancer; 2023 May; 24(3):e141-e151. PubMed ID: 36639280
[TBL] [Abstract][Full Text] [Related]
44. Surgery or Non-surgical Treatment of ≤8 mm Non-small Cell Lung Cancer: A Population-Based Study.
Shen J; Zhuang W; Xu C; Jin K; Chen B; Tian D; Hiley C; Onishi H; Zhu C; Qiao G
Front Surg; 2021; 8():632561. PubMed ID: 34124131
[No Abstract] [Full Text] [Related]
45. Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study.
Zhao K; Xia C; Qiu M; Yang Z; Cui T; Song T; Li S; Mei H; Zheng Y; Wang H
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16679-16690. PubMed ID: 37725243
[TBL] [Abstract][Full Text] [Related]
46. Sublobar resection reduces the risk of postoperative cognitive dysfunction compared with lobectomy.
Zang N; Shen W; Li S; Chen L; Ai Q; Huang W; Lan L; Liu J; Wang W; Cui F; Huang J; Shao W; Huang X; Xu P; He J
Eur J Cardiothorac Surg; 2023 Nov; 64(5):. PubMed ID: 37713465
[TBL] [Abstract][Full Text] [Related]
47. Survival and Long-Term Cause-Specific Mortality Associated With Stage IA Lung Adenocarcinoma After Wedge Resection vs. Segmentectomy: A Population-Based Propensity Score Matching and Competing Risk Analysis.
Zhao M; Lu T; Huang Y; Yin J; Jiang T; Li M; Yang X; Zhan C; Feng M; Wang Q
Front Oncol; 2019; 9():593. PubMed ID: 31334118
[No Abstract] [Full Text] [Related]
48. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
[TBL] [Abstract][Full Text] [Related]
49. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
50. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data.
Kates M; Swanson S; Wisnivesky JP
Chest; 2011 Mar; 139(3):491-496. PubMed ID: 20576736
[TBL] [Abstract][Full Text] [Related]
51. Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.
Liu Y; Shan L; Shen J; Liu L; Wang J; He J; He Q; Jiang L; Guo M; Chen X; Zeng H; Xia X; Peng G; Liang W; He J
Thorac Cancer; 2019 Apr; 10(4):593-600. PubMed ID: 30854808
[TBL] [Abstract][Full Text] [Related]
52. Lobectomy is superior to segmentectomy for peripheral high grade non-small cell lung cancer ≤2 cm.
Baig MZ; Razi SS; Weber JF; Connery CP; Bhora FY
J Thorac Dis; 2020 Oct; 12(10):5925-5933. PubMed ID: 33209425
[TBL] [Abstract][Full Text] [Related]
53. Lung Segmentectomy in NSCLC Surgery.
Salvicchi A; Tombelli S; Mugnaini G; Gonfiotti A
Life (Basel); 2023 May; 13(6):. PubMed ID: 37374067
[TBL] [Abstract][Full Text] [Related]
54. Surgical modality for stage IA non-small cell lung cancer among the elderly: analysis of the Surveillance, Epidemiology, and End Results database.
Wang W; Sun Y; Li H; Bao M; Liu X; Jiang G; Ye C; Hu Y
J Thorac Dis; 2020 Nov; 12(11):6731-6742. PubMed ID: 33282374
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
[TBL] [Abstract][Full Text] [Related]
56. Lobectomy versus sublobar resection for stage I (T1-T2aN0M0) small cell lung cancer: A SEER population-based propensity score matching analysis.
Zhou N; Yang L; Zhang B; Zhu S; Huo H; He J; Zu L; Song Z; Xu S
Cancer Med; 2023 Apr; 12(7):7923-7931. PubMed ID: 36567517
[TBL] [Abstract][Full Text] [Related]
57. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
[TBL] [Abstract][Full Text] [Related]
58. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
Speicher PJ; Gu L; Gulack BC; Wang X; D'Amico TA; Hartwig MG; Berry MF
Clin Lung Cancer; 2016 Jan; 17(1):47-55. PubMed ID: 26602547
[TBL] [Abstract][Full Text] [Related]
59. A nomogram to predict prognosis in patients undergoing sublobar resection for stage IA non-small-cell lung cancer.
Yang H; Li X; Shi J; Fu H; Yang H; Liang Z; Xiong H; Wang H
Cancer Manag Res; 2018; 10():6611-6626. PubMed ID: 30584357
[TBL] [Abstract][Full Text] [Related]
60. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
Gao L; Shen L; Wang K; Lu S
Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
